Credit Suisse’s Abiomed Inc ABMD Stock Holding History

Credit Suisse’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-353,961	Closed	-$87M	–	4198
2022 Q3	$87M	Sell	353,961 -22,337	-6%	-$6.03M	0.1%	215
2022 Q2	$93.1M	Sell	376,298 -45,595	-11%	-$12.3M	0.1%	220
2022 Q1	$140M	Sell	421,893 -211,031	-33%	-$65M	0.12%	173
2021 Q4	$227M	Sell	632,924 -108,522	-15%	-$36.7M	0.12%	151
2021 Q3	$241M	Sell	741,446 -111,340	-13%	-$37.7M	0.13%	140
2021 Q2	$266M	Sell	852,786 -53,204	-6%	-$16.3M	0.14%	141
2021 Q1	$289M	Buy	905,990 +216,404	+31%	+$69.3M	0.15%	124
2020 Q4	$224M	Buy	689,586 +44,979	+7%	+$12.4M	0.11%	190
2020 Q3	$179M	Sell	644,607 -78,622	-11%	-$22.7M	0.11%	189
2020 Q2	$175M	Sell	723,229 -29,835	-4%	-$5.99M	0.13%	156
2020 Q1	$109M	Buy	753,064 +140,097	+23%	+$23.3M	0.09%	199
2019 Q4	$105M	Buy	612,967 +352,578	+135%	+$65.4M	0.08%	262
2019 Q3	$46.3M	Buy	260,389 +56,323	+28%	+$12.2M	0.04%	485
2019 Q2	$53.2M	Buy	204,066 +14,018	+7%	+$3.72M	0.05%	416
2019 Q1	$54.3M	Buy	190,048 +13,919	+8%	+$4.63M	0.05%	392
2018 Q4	$57.2M	Buy	176,129 +43,405	+33%	+$15.1M	0.06%	331
2018 Q3	$59.7M	Buy	132,724 +29,503	+29%	+$11.6M	0.05%	364
2018 Q2	$42.2M	Buy	103,221 +52,891	+105%	+$19.2M	0.04%	452
2018 Q1	$14.6M	Sell	50,330 -4,423	-8%	-$1.12M	0.01%	1025
2017 Q4	$10.3M	Buy	54,753 +9,845	+22%	+$1.84M	0.01%	1269
2017 Q3	$7.57M	Sell	44,908 -19,733	-31%	-$2.98M	0.01%	1432
2017 Q2	$9.26M	Sell	64,641 -4,825	-7%	-$648K	0.01%	1250
2017 Q1	$8.7M	Sell	69,466 -4,730	-6%	-$548K	0.01%	1292
2016 Q4	$8.36M	Sell	74,196 -8,175	-10%	-$947K	0.01%	1310
2016 Q3	$10.6M	Sell	82,371 -46,622	-36%	-$5.58M	0.01%	1149
2016 Q2	$14.1M	Buy	128,993 +61,339	+91%	+$6.1M	0.02%	963
2016 Q1	$6.42M	Buy	67,654 +14,932	+28%	+$1.26M	0.01%	1375
2015 Q4	$4.76M	Sell	52,722 -21,009	-28%	-$1.78M	0.01%	1620
2015 Q3	$6.84M	Sell	73,731 -2,905	-4%	-$256K	0.01%	1348
2015 Q2	$5.04M	Sell	76,636 -43,106	-36%	-$2.86M	﹤0.01%	1728
2015 Q1	$8.57M	Sell	119,742 -240	-0.2%	-$13K	0.01%	1294
2014 Q4	$4.57M	Sell	119,982 -22,981	-16%	-$725K	﹤0.01%	1842
2014 Q3	$3.55M	Sell	142,963 -2,413	-2%	-$61.1K	﹤0.01%	2024
2014 Q2	$3.65M	Sell	145,376 -12,841	-8%	-$299K	﹤0.01%	2227
2014 Q1	$4.12M	Buy	158,217 +6,481	+4%	+$179K	﹤0.01%	1928
2013 Q4	$4.06M	Sell	151,736 -31,285	-17%	-$773K	﹤0.01%	2010
2013 Q3	$3.49M	Buy	183,021 +39,833	+28%	+$911K	﹤0.01%	1935
2013 Q2	$3.09M	Buy	+143,188	New	+$2.88M	﹤0.01%	1954

Other funds holding ABMD

TRSOTSOK

Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Credit Suisse's ABMD Position: Q4 2022 in Review

Credit Suisse sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 353,961 shares — an estimated $87M sold.

Credit Suisse first reported a position in ABMD in Q2 2013 and held it in 38 quarters. The position peaked at $289M in Q1 2021. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

Credit Suisse reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
Credit Suisse sold 353,961 Abiomed Inc shares in Q4 2022, an estimated $87M.
Credit Suisse first reported a position in Abiomed Inc in Q2 2013 and held it in 38 quarters.
Credit Suisse's Abiomed Inc position peaked at $289M in Q1 2021.
8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Credit Suisse's 13F filing for Q4 2022, filed 13 Feb 2023.